Close search

Latest news

Vancomycin Side Effects
8 Aug 2020 | Blog

Vancomycin Side Effects

Vancomycin (brand name: Vancocin®) is an antibiotic that can be used for multiple severe bacterial infections. When first approved by the FDA in the 1950’s, vancomycin was less pure than it is today1, resulting in a higher risk of side effects. Even though the medication was effective...

Read more
New Study Finds DoseMeRx Increases Vancomycin AUC Target Attainment
1 Jul 2020 | Latest News

New Study Finds DoseMeRx Increases Vancomycin AUC Target Attainment

A recent study by University Hospitals of Leicester NHS Trust, published in the British Journal of Pharmacology (BJCP), found DoseMeRx (a bed-side Bayesian dosing software)  increased the number of vancomycin patients achieving two clinically important targets - Area...

Read more
Implementing the 2020 Vancomycin Guidelines: Webinar Recording
10 Jun 2020 | Blog

Implementing the 2020 Vancomycin Guidelines: Webinar Recording

Wondering how to implement the new 2020 vancomycin dosing guidelines? DoseMeRx is here to help! Watch this four part webinar recording as one of the primary guidelines authors, Dr. Tom Lodise and Cedars-Sinai Medical Center AMS Coordinator, Dr. Ethan Smith guide you through...

Read more
Intravenous Vancomycin
3 Jun 2020 | Blog

Intravenous Vancomycin

Vancomycin is an antibiotic originally isolated from the bacteria Streptococcus orientalis.  It was discovered in the 1950's but became a preferred treatment against infections resistant to other antibiotics, particularly penicillin-resistant staphylococcal infections. Vancomycin is a tricyclic glycopeptide antibiotic that prevents synthesis of peptidoglycan, the main...

Read more
Vanco AUC Conversion Toolkit 📝Download Now →

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2020 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.